Woodside Energy Group Ltd
WDS
Origin Energy Ltd
ORG
National Australia Bank Ltd
NAB
Telstra Group Ltd
TLS
ANZ Group Holdings Ltd
ANZ
AU Stock MarketDetailed Quotes
PER Percheron Therapeutics Ltd
- 0.007
- 0.0000.00%
20min DelayMarket Closed Dec 24 14:10 AET
7.61MMarket Cap-0.50P/E (Static)
0.008High0.007Low10.33MVolume0.007Open0.007Pre Close72.34KTurnover0.14052wk High1.16%Turnover Ratio1.09BShares0.00552wk Low-0.014EPS TTM6.24MFloat Cap0.140Historical HighLossP/E (Static)891.65MShs Float0.005Historical Low-0.014EPS LYR14.29%Amplitude--Dividend TTM0.78P/B1Lot Size--Div YieldTTM
About Percheron Therapeutics Ltd Company
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.
Company Profile
SymbolPER
Company NamePercheron Therapeutics Ltd
Founded2000
MarketASX
Employees3
Fiscal Year Ends06-30
Address14 Wallace Avenue LEVEL 1
CityToorak
CountryAustralia
Zip Code3142
Phone+61 398278999
Websitehttps://www.percherontx.com
Share RegistryBOARDROOM PTY LIMITED
LEVEL 8, 210 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
(02) 9290 9600
Company Executives
- Name
- Position
- Salary
- James Garner
- Chief Executive Officer,Managing Director
- --
- Charmaine Gittleson
- Executive Chairman,Executive Director
- --
- Ben Gil Price
- Non-Executive Director
- --